$TER

Smith Gregory Stephen sold $1.7M of TER

Smith Gregory Stephen (President and CEO) sold 4,000 shares of TERADYNE, INC (TER) at $423.03 ($1.69M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Gregory Stephen
Published Jun 16, 2026, 9:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
medium confidence
Mentioned
$TER
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The disclosure adds a fresh, timestamped data point on insider activity, but it does not include any new company fundamentals (earnings, guidance, contracts, or regulatory actions).

02

Market read

Insider selling can influence short-term sentiment, but 10b5-1 context usually limits trading impact absent other catalysts.

03

What to watch

Traders may ignore that the CEO’s holdings remain substantial (120,470 shares after sale), and that the article provides no accompanying guidance, performance, or legal/product developments.

Relevance 5/10Novelty 8/10Timing: SEC Form 4 filed June 16 for a June 15 sale

Background

The article reports an SEC Form 4 insider transaction for Teradyne, Inc. (TER) by its President and CEO.

Company-level read

Ticker impact

$TERNeutralMedium confidence
Context

Teradyne CEO Smith Gregory Stephen sold 4,000 shares on a pre-arranged 10b5-1 plan for about $1.69M, per Form 4 filed June 16.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is primary-source and time-stamped, but the sale is explicitly under a pre-arranged 10b5-1 plan, which reduces interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider transaction with no stated operational or sector catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is on a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish fundamentals—so any negative read-through could be overdone.

Key entities

  • TERADYNE, INC

    US-listed company whose CEO filed an SEC Form 4 insider sale.

  • Smith Gregory Stephen

    President and CEO who sold 4,000 shares under a pre-arranged 10b5-1 plan.

Related articles

$TERMed

5 Revealing Analyst Questions From Teradyne’s Q2 Earnings Call

Teradyne reported Q2 revenue of $1.33B vs $1.22B expected and adjusted EPS of $2.47 vs $2.05, citing AI-driven demand across semiconductor test, product test, and robotics. CEO Gregory Smith said over 60% of revenue is AI-related. Q3 guidance calls for $1.25B revenue and $2.00 adjusted EPS at midpoint. Analysts asked about test equipment share, wafer-to-data-center strategy, memory drivers, and CPU vs GPU testing.

$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne (NASDAQ: TER) shares rose about 3.3% midday after Q2 results and guidance beat expectations. The company reported non-GAAP EPS of $2.47 on revenue of $1.33B, topping analyst forecasts by $0.42 and about $110M, respectively. Q3 guidance calls for revenue $1.2B to $1.3B and adjusted EPS $1.85 to $2.15, both above estimates, though gains eased amid broader macro concerns.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

$TERMed

Why Teradyne (TER) Stock Is Trading Up Today

Teradyne (NASDAQ: TER) shares rose about 12.5% after the company reported strong Q2 results. Revenue was about $1.3 billion, more than double year over year, driven by demand for AI test equipment. Management said AI-related orders now exceed 60% of the business. The move followed broader semiconductor weakness tied to China and AI demand concerns.

$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne shares rose 3.3% around 1 p.m. ET despite declines in the S&P 500 and Nasdaq. After reporting Q2 results, the company posted non-GAAP EPS of $2.47 on revenue of $1.33B, beating analyst expectations, and provided Q3 guidance of $1.2B to $1.3B revenue and $1.85 to $2.15 adjusted EPS.